Incidental Mutation 'R0333:Spata2l'
ID 38338
Institutional Source Beutler Lab
Gene Symbol Spata2l
Ensembl Gene ENSMUSG00000033594
Gene Name spermatogenesis associated 2-like
Synonyms 2610039E05Rik
MMRRC Submission 038542-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.070) question?
Stock # R0333 (G1)
Quality Score 102
Status Validated
Chromosome 8
Chromosomal Location 123958994-123962997 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 123960371 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Phenylalanine to Serine at position 306 (F306S)
Ref Sequence ENSEMBL: ENSMUSP00000130306 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000036880] [ENSMUST00000098327] [ENSMUST00000127664] [ENSMUST00000166768] [ENSMUST00000213005] [ENSMUST00000212193] [ENSMUST00000212361] [ENSMUST00000212818]
AlphaFold Q8BNN1
Predicted Effect probably benign
Transcript: ENSMUST00000036880
SMART Domains Protein: ENSMUSP00000045527
Gene: ENSMUSG00000033862

DomainStartEndE-ValueType
S_TKc 39 323 1.52e-87 SMART
Predicted Effect probably damaging
Transcript: ENSMUST00000098327
AA Change: F306S

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000095932
Gene: ENSMUSG00000033594
AA Change: F306S

DomainStartEndE-ValueType
low complexity region 74 91 N/A INTRINSIC
low complexity region 209 214 N/A INTRINSIC
low complexity region 294 308 N/A INTRINSIC
low complexity region 309 318 N/A INTRINSIC
low complexity region 340 347 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000127664
SMART Domains Protein: ENSMUSP00000118564
Gene: ENSMUSG00000092329

DomainStartEndE-ValueType
Pfam:Glycos_transf_2 104 287 7.4e-31 PFAM
Pfam:Glyco_transf_7C 261 331 4.9e-8 PFAM
RICIN 406 531 9.28e-27 SMART
Predicted Effect probably damaging
Transcript: ENSMUST00000166768
AA Change: F306S

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000130306
Gene: ENSMUSG00000033594
AA Change: F306S

DomainStartEndE-ValueType
low complexity region 74 91 N/A INTRINSIC
low complexity region 209 214 N/A INTRINSIC
low complexity region 294 308 N/A INTRINSIC
low complexity region 309 318 N/A INTRINSIC
low complexity region 340 347 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000181432
Predicted Effect noncoding transcript
Transcript: ENSMUST00000211845
Predicted Effect noncoding transcript
Transcript: ENSMUST00000211876
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212532
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212749
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212784
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212904
Predicted Effect probably benign
Transcript: ENSMUST00000213005
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212021
Predicted Effect probably benign
Transcript: ENSMUST00000212193
Predicted Effect probably benign
Transcript: ENSMUST00000212361
Predicted Effect probably benign
Transcript: ENSMUST00000212818
Predicted Effect noncoding transcript
Transcript: ENSMUST00000212497
Meta Mutation Damage Score 0.2031 question?
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.4%
  • 10x: 96.7%
  • 20x: 93.8%
Validation Efficiency 100% (53/53)
Allele List at MGI
Other mutations in this stock
Total: 49 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Alas1 T C 9: 106,118,480 (GRCm39) N214S probably benign Het
Antxr1 A G 6: 87,165,820 (GRCm39) probably benign Het
Atxn7l3 A T 11: 102,185,818 (GRCm39) probably null Het
Cab39l A G 14: 59,737,060 (GRCm39) E60G probably damaging Het
Cdc5l G T 17: 45,704,142 (GRCm39) probably benign Het
Cux2 T C 5: 121,998,671 (GRCm39) E1423G probably benign Het
Dbndd1 G T 8: 124,233,512 (GRCm39) Q165K probably damaging Het
Drd1 C A 13: 54,208,082 (GRCm39) C37F probably damaging Het
Elp3 G A 14: 65,828,042 (GRCm39) P11L probably benign Het
F830045P16Rik A G 2: 129,314,777 (GRCm39) Y167H probably damaging Het
Gimap3 G A 6: 48,742,664 (GRCm39) Q89* probably null Het
H2ac25 C A 11: 58,845,685 (GRCm39) S41* probably null Het
Herc1 G A 9: 66,371,981 (GRCm39) probably null Het
Ipo11 A G 13: 107,007,271 (GRCm39) V603A probably benign Het
Kifap3 G A 1: 163,624,833 (GRCm39) A130T probably damaging Het
Klhl23 A G 2: 69,664,241 (GRCm39) Y530C probably damaging Het
Map4k1 C T 7: 28,699,186 (GRCm39) probably benign Het
Mroh2b T A 15: 4,960,600 (GRCm39) L778M probably damaging Het
Mtdh T C 15: 34,118,247 (GRCm39) S344P possibly damaging Het
Ncoa3 T G 2: 165,896,211 (GRCm39) N371K probably damaging Het
Ncor2 C A 5: 125,111,408 (GRCm39) probably benign Het
Nrn1l A G 8: 106,621,052 (GRCm39) E48G probably benign Het
Nudcd1 A G 15: 44,264,683 (GRCm39) I271T probably benign Het
Or1e17 A T 11: 73,831,593 (GRCm39) I174F possibly damaging Het
Or2t1 T C 14: 14,328,498 (GRCm38) L129P probably damaging Het
Pard3b A G 1: 62,269,371 (GRCm39) N653S probably benign Het
Plekhg1 A C 10: 3,914,419 (GRCm39) K1380N probably damaging Het
Ppara T A 15: 85,675,161 (GRCm39) I210N probably damaging Het
Ppp2r5b A G 19: 6,279,077 (GRCm39) probably benign Het
Prkn T C 17: 11,286,027 (GRCm39) F6L probably damaging Het
Prr14l A G 5: 32,985,337 (GRCm39) L1386P probably damaging Het
Ralgapa1 A G 12: 55,829,685 (GRCm39) probably benign Het
Reln A T 5: 22,134,240 (GRCm39) L2563I probably damaging Het
Rps7 A G 12: 28,681,200 (GRCm39) probably benign Het
Rslcan18 T C 13: 67,246,686 (GRCm39) K309E probably damaging Het
Sec14l5 C T 16: 4,984,930 (GRCm39) T92M probably damaging Het
Slc22a8 G A 19: 8,585,514 (GRCm39) probably benign Het
Smad2 G A 18: 76,395,692 (GRCm39) A44T probably damaging Het
Smcr8 T C 11: 60,671,048 (GRCm39) V732A possibly damaging Het
Stab2 T C 10: 86,677,491 (GRCm39) D2552G probably benign Het
Tctn3 A T 19: 40,595,711 (GRCm39) L358H possibly damaging Het
Tk2 C T 8: 104,975,146 (GRCm39) probably benign Het
Tm6sf2 C T 8: 70,530,564 (GRCm39) R215C probably damaging Het
Tmbim6 T C 15: 99,304,555 (GRCm39) I204T probably damaging Het
Tubgcp2 C A 7: 139,579,260 (GRCm39) W675C probably damaging Het
Usp48 T A 4: 137,321,794 (GRCm39) I62N probably damaging Het
Vmn2r74 T C 7: 85,601,491 (GRCm39) T716A probably benign Het
Vps13b C A 15: 35,879,949 (GRCm39) T3008K probably damaging Het
Wnk1 G A 6: 119,905,124 (GRCm39) probably benign Het
Other mutations in Spata2l
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00909:Spata2l APN 8 123,960,716 (GRCm39) missense possibly damaging 0.79
IGL01764:Spata2l APN 8 123,960,914 (GRCm39) missense probably benign 0.16
IGL02145:Spata2l APN 8 123,960,770 (GRCm39) missense possibly damaging 0.83
IGL03145:Spata2l APN 8 123,960,075 (GRCm39) missense possibly damaging 0.73
R1351:Spata2l UTSW 8 123,960,072 (GRCm39) missense probably damaging 1.00
R1647:Spata2l UTSW 8 123,960,041 (GRCm39) missense probably benign
R4420:Spata2l UTSW 8 123,960,768 (GRCm39) missense possibly damaging 0.80
R5161:Spata2l UTSW 8 123,962,288 (GRCm39) missense probably damaging 1.00
R5770:Spata2l UTSW 8 123,962,459 (GRCm39) missense probably damaging 0.98
R6668:Spata2l UTSW 8 123,960,167 (GRCm39) missense probably damaging 1.00
R6885:Spata2l UTSW 8 123,962,297 (GRCm39) missense probably damaging 1.00
R8513:Spata2l UTSW 8 123,960,438 (GRCm39) missense probably benign
R9310:Spata2l UTSW 8 123,960,873 (GRCm39) missense probably benign 0.33
Predicted Primers PCR Primer
(F):5'- CACGAAGGCTCTACCCTCTTTCAAC -3'
(R):5'- TCAGAGGCCAGTCTGTATGGTGAG -3'

Sequencing Primer
(F):5'- GACTGTCATAGAGCAGGTTATCCAC -3'
(R):5'- TATGGTGAGCCTTCCCCAG -3'
Posted On 2013-05-23